Cn1cc(CN2C[C@]3(C)C[C@H]2CC(C)(C)C3)c(-c2ccc3c(c2)OCCO3)n1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?